Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Santarus, Inc. (NASDAQ:SNTS.DL)

CAPS Rating: No stars

A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SNTS.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

WilliamCrook2003 (71.18)
Submitted August 06, 2013

MF Stock of the Day

cvdynasty3 (38.20)
Submitted December 02, 2009

FDA will not approve... Inside info boys!!!Will lose 20-25 pct easily, FDA will need more data

NASDAQ:SNTS.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SNTS.DL.

No one has written a Pitch for SNTS.DL stock yet. Tell us why you think SNTS.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in SNTS.DL.

No players have picked SNTS.DL yet. Tell us why you think SNTS.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SNTS.DL.